These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7368220)

  • 1. Chemiluminescence from rat alveolar macrophages following induction of phospholipidosis with chlorphentermine.
    Reasor MJ; Koshut RA; McNulty MJ; Trush MA
    Toxicol Appl Pharmacol; 1980 Mar; 52(3):497-506. PubMed ID: 7368220
    [No Abstract]   [Full Text] [Related]  

  • 2. Chlorphentermine-induced phospholipidosis in rat alveolar macrophages--luminol-dependent chemiluminescence.
    Reasor MJ
    Biochem Pharmacol; 1981 Jan; 30(2):165-8. PubMed ID: 7236305
    [No Abstract]   [Full Text] [Related]  

  • 3. Recovery from chlorphentermine-induced phospholipidosis in rat alveolar macrophages: biochemical and cellular features.
    Reasor MJ; Castranova V
    Exp Mol Pathol; 1981 Dec; 35(3):359-69. PubMed ID: 6796431
    [No Abstract]   [Full Text] [Related]  

  • 4. Augmentation in antioxidant defense mechanisms in rat alveolar macrophages following induction of phospholipidosis with chlorphentermine.
    Reasor MJ; Koshut RA
    Toxicol Appl Pharmacol; 1980 Sep; 55(2):334-41. PubMed ID: 7423522
    [No Abstract]   [Full Text] [Related]  

  • 5. Recovery from chlorphentermine-induced phospholipidosis in rat alveolar macrophages: morphological features.
    Reasor MJ; Walker ER
    Exp Mol Pathol; 1981 Dec; 35(3):370-9. PubMed ID: 7308413
    [No Abstract]   [Full Text] [Related]  

  • 6. Cumene hydroperoxide-mediated lipid peroxidation in rat alveolar macrophages following induction of phospholipidosis with chlorphentermine.
    Reasor MJ
    Toxicology; 1980; 18(2):159-68. PubMed ID: 7256780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the alveolar macrophage in the induction of pulmonary phospholipidosis by chlorphentermine. I. Drug and phospholipid levels.
    Heyneman CA; Reasor MJ
    J Pharmacol Exp Ther; 1986 Jan; 236(1):55-9. PubMed ID: 3941400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the alveolar macrophage in the induction of pulmonary phospholipidosis by chlorphentermine. II. Drug uptake into cells in vitro.
    Heyneman CA; Reasor MJ
    J Pharmacol Exp Ther; 1986 Jan; 236(1):60-4. PubMed ID: 3941401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of drug-induced phospholipidosis on pulmonary disposition of pneumophilic drugs.
    Ohmiya Y; Angevine LS; Mehendale HM
    Drug Metab Dispos; 1983; 11(1):25-30. PubMed ID: 6132791
    [No Abstract]   [Full Text] [Related]  

  • 10. Alterations in rat alveolar surfactant phospholipids and proteins induced by administration of chlorphentermine.
    Miles PR; Bowman L; Tucker J; Reasor MJ; Wright JR
    Biochim Biophys Acta; 1986 Jun; 877(1):167-78. PubMed ID: 3755061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of a pre-existing phospholipidosis on the accumulation of amiodarone and desethylamiodarone in rat alveolar macrophages.
    Reasor MJ
    Res Commun Chem Pathol Pharmacol; 1991 May; 72(2):169-81. PubMed ID: 1876748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in lysosomal properties of alveolar macrophages of rats treated with chlorphentermine.
    Reasor MJ; Trush MA; Walker ER
    Toxicol Appl Pharmacol; 1978 Oct; 46(1):261-4. PubMed ID: 725948
    [No Abstract]   [Full Text] [Related]  

  • 13. Phospholipidosis in the alveolar macrophage induced by cationic amphiphilic drugs.
    Reasor MJ
    Fed Proc; 1984 Aug; 43(11):2578-81. PubMed ID: 6745447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multinucleation in alveolar macrophages from rats treated with chlorphentermine.
    Reasor MJ; Massey CA; Koshut RA; Castranova V
    Lab Invest; 1982 Feb; 46(2):224-30. PubMed ID: 6174825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysosomal stabilizing effect of chlorphentermine in the rabbit alveolar macrophage.
    Reasor MJ; Walker ER
    Gen Pharmacol; 1979; 10(2):83-8. PubMed ID: 437485
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug-induced phospholipidosis. I. Lipid composition and chlorphentermine content of rat lung tissue and alveolar macrophages after chronic treatment.
    Schmien R; Seiler KU; Wassermann O
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 283(3):331-4. PubMed ID: 4276759
    [No Abstract]   [Full Text] [Related]  

  • 17. Cytochemical demonstration of increased phospholipid content in cell membranes in chlorphentermine-induced phospholipidosis.
    Coulombe PA; Bendayan M
    J Histochem Cytochem; 1989 Feb; 37(2):139-47. PubMed ID: 2911004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iprindole-induced phospholipidosis in rat alveolar macrophages: alterations in oxygen consumption and release of oxidants.
    McNulty MJ; Reasor MJ
    Exp Lung Res; 1981 Mar; 2(1):57-69. PubMed ID: 6286298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical characteristics of rat alveolar macrophages with chlorphentermine-induced phospholipidosis: variations with increasing cell size.
    Reasor MJ; Koshut RA; Castranova V
    Exp Mol Pathol; 1979 Oct; 31(2):297-307. PubMed ID: 467619
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of drug metabolism in protection against chlorphentermine-induced pulmonary phospholipidosis in adult rat.
    Kacew S; Narbaitz R; Ruddick JA; Villeneuve DC
    Exp Mol Pathol; 1981 Aug; 35(1):98-107. PubMed ID: 7250339
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.